Oral preexposure prophylaxis to prevent HIV infection: Clinical and public health implications

被引：1

作者：

Baker, Jonathan ^{[1
]}

O'Hara, Kevin Michael ^{[2
]}

机构：

[1] Univ Pittsburgh Pa Med Ctr, Div Infect Dis, Pittsburgh, PA 15261 USA

[2] Yale Univ, PA Program, New Haven, CT USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2014年 / 27卷 / 12期

关键词：

HIV; preexposure prophylaxis (PrEP); tenofovir; emtricitabine (FTC); antiretroviral; harm reduction; TENOFOVIR DISOPROXIL FUMARATE; IMMUNODEFICIENCY-VIRUS; UNITED-STATES; ANTIRETROVIRAL PROPHYLAXIS; COST-EFFECTIVENESS; MEN; RISK; SEX; TRANSMISSION; EMTRICITABINE;

D O I：

10.1097/01.JAA.0000456567.37724.e0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article reviews the use of combination emtricitabine (FTC)/tenofovir as preexposure prophylaxis (PrEP) for HIV-negative patients at high risk of acquiring HIV, including heterosexual men and women, men who have sex with men, and IV drug users. When used with classic prevention strategies such as condoms, PrEP has been found effective in reducing the risk of HIV transmission.

引用

页码：10 / 17

页数：8

共 50 条

[31] Preexposure prophylaxis for preventing HIV infection: Routine practice in primary care
Wiser, Amy L.
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (06) : 361 - 371
[32] HIV diagnosis during acute infection: implications of long-acting preexposure prophylaxis and other evolving challenges
Elliott, Tamara
Bradshaw, Daniel
Fidler, Sarah
CURRENT OPINION IN HIV AND AIDS, 2025, 20 (03) : 228 - 235
[33] Pre-Exposure Prophylaxis for HIV Infection as a Public Health Tool
Beyrer, Chris
McCormack, Sheena
Grulich, Andrew
JOURNAL OF LAW MEDICINE & ETHICS, 2022, 50 : 24 - 28
[34] Gaps in Preexposure Prophylaxis Uptake for HIV Prevention in the Veterans Health Administration
Garner, Will
Wilson, Brigid M.
Beste, Lauren
Maier, Marissa
Ohl, Michael E.
Van Epps, Puja
AMERICAN JOURNAL OF PUBLIC HEALTH, 2018, 108 : S305 - S310
[35] Safety of oral tenofovir disoproxil-emtricitabine for HIV preexposure prophylaxis in adults
Liegeon, Geoffroy
CURRENT OPINION IN HIV AND AIDS, 2022, 17 (04) : 199 - 204
[36] HIV preexposure prophylaxis treatment patterns in a national health plan population
Rastegar, Jeremiah
Hu, Amy
Chung, Linda
Stevens, Lauren
Dixon, Suzanne W.
Schwab, Phil
Ellis, Jeffrey J.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (12): : 1267 - 1274
[37] Predictors of HIV Preexposure Prophylaxis Initiation Among Public Health Clients in Rural and Small Urban Areas in Iowa
Howren, M. Bryant
Francis, Shelby L.
Polgreen, Linnea A.
Shafer, Cody
Hoth, Angela
Ohl, Michael E.
PUBLIC HEALTH REPORTS, 2021, 136 (02) : 172 - 182
[38] Risk Compensation and Clinical Decision Making - The Case of HIV Preexposure Prophylaxis
Marcus, Julia L.
Katz, Kenneth A.
Krakower, Douglas S.
Calabrese, Sarah K.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (06): : 510 - 512
[39] Preexposure Prophylaxis Monitoring in New York City: A Public Health Approach
Myers, Julie E.
Edelstein, Zoe R.
Daskalakis, Demetre C.
Gandhi, Anisha D.
Misra, Kavita
Rivera, Alexis V.
Salcuni, Paul M.
Scanlin, Kathleen
Udeagu, Chi-Chi
Braunstein, Sarah L.
AMERICAN JOURNAL OF PUBLIC HEALTH, 2018, 108 : S251 - S257
[40] Preexposure prophylaxis for HIV prevention: A highlight of the updated clinical practice guideline
Mayeux, Jack J.
Ng, Yeow Chye
NURSE PRACTITIONER, 2022, 47 (09): : 44 - 47

← 1 2 3 4 5 →